Search

Search Constraints

You searched for: Author/Creator Xu, Z.

Search Results

7. 59MO Final analysis of AK105-302: A randomized, double-blind, placebo-controlled, phase III trial of penpulimab plus carboplatin and paclitaxel as first-line treatment for advanced squamous NSCLC. (December 2022)